©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 28, 2005; 11(44): 6941-6947
Published online Nov 28, 2005. doi: 10.3748/wjg.v11.i44.6941
Published online Nov 28, 2005. doi: 10.3748/wjg.v11.i44.6941
Table 5 TRFL and t/n TRFLR of the tumor tissues according to the telomerase expression and TNM stages
| Variables | TRFL | P- values | t/n TRFLR | P- values |
| Tissues | <0.00011 | |||
| Normal | 4.93±1.74 kb | |||
| Tumor | 2.70±1.42 kb | |||
| Telomerase | 0.7671 | 0.7422 | ||
| Positive | 2.72±1.44 kb | 0.55±0.22 | ||
| Negative | 2.58±1.32 kb | 0.59±0.41 | ||
| Tumor stages | 0.9362 | 0.8672 | ||
| Stage I | 3.04±0.42 kb | 0.818±0.019 | ||
| Stage II | 2.65±1.44 kb | 0.686±0.184 | ||
| Stage III | 2.83±1.44 kb | 0.729±0.265 | ||
| Stage IV | 2.41±1.49 kb | 0.649±0.185 | ||
| Total | 2.70±1.42 kb | 0.73±0.24 |
- Citation: Hsu CP, Lee LW, Shai SE, Chen CY. Clinical significance of telomerase and its associate genes expression in the maintenance of telomere length in squamous cell carcinoma of the esophagus. World J Gastroenterol 2005; 11(44): 6941-6947
- URL: https://www.wjgnet.com/1007-9327/full/v11/i44/6941.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i44.6941